Todaro Robotics is a laboratory systems integrator for automation and robotics, helping biotech, pharma, and life science companies automate their experiments and their processes, with clients from the startup size all the way to large corporations, such as Eli Lilly. In my conversation with co-founder James Slatic, we talk about the addition of product development to their company in addition to the consultation services they provide, and the integration and growth of both sides of the company. 

We also talk about some of the struggles of launching a business where you’re not the smartest guy in the room. You know how to build and run companies, but don’t necessarily understand all the science. I enjoyed this conversation and I truly hope you do as well. Find James on social media, and be sure to thank him for coming on the podcast, and thank you for listening.

Topics in this episode

Changes within the industry as a result of covid, and the shift toward automation

The science of DNA purification

Approaching a technology that is already in the market, yet coming at it from a different angle

Differences in the rate of growth as your company grows 

The role of consultants in the biotech, life science, and pharma industries from individual consultants up to large firms

The roll-up process of combining with complementary companies and either going public or becoming an acquisition candidate

Limiting legal risk between consultation services and product company

Revisiting growth strategies as you evolve

Tactics for working in an industry where your clients are technically skilled in a way that you aren’t 

Contact Info

Website